No Detail Found!

Mid-term clinical outcomes of zotarolimus-eluting stent in patients with stable angina pectoris

Author(s)
Yasir Adnan Lady Reading Hospital & Khyber Medical University, Peshawar ,Pakistan
Shahab Ud Din Medical A unit, Ayub Teaching Hospital, Abbottabad
Lubna Noor Lady Reading Hospital & Khyber Medical University, Peshawar ,Pakistan
Farooq Ahmad Lady Reading Hospital & Khyber Medical University, Peshawar ,Pakistan
Syed Tahir Shah Lady Reading Hospital & Khyber Medical University, Peshawar ,Pakistan
Adnan Mahmood Gul Lady Reading Hospital & Khyber Medical University, Peshawar ,Pakistan
Mohammad Hafizullah Lady Reading Hospital & Khyber Medical University, Peshawar ,Pakistan
Abstract
Objectives: The study was designed to evaluate the safety and effectiveness of the Endeavor zotarolimus-eluting stent (ZES) for the treatment of stable coronary artery disease. Methodology: This was a cross sectional descriptive study. Patients who were admitted to Cardiology Unit of Lady Reading Hospital, Peshawar, through OPD or casualty department, fulfilling the inclusion criteria were enrolled in the study. This study included all the patients with stable coronary artery disease who had received Endeavor stents from January 2010, to March 2011. Total study duration was 15 months. The primary end point was the rate of major adverse cardiac events (MACE) at 12 months. All patients who underwent PCI with Endeavor stent implant for stable angina pectoris were followed up and reassessed after 12 months from the index procedure. Results: A total of 128 patients were included in the study. Mean age was 54 ±2.4years. Male were 91 (71.1 %) while females were 37 (28.9). Of these 49.2% were hypertensive, 28.9% diabetic, 19.5% smokers, and 39.8% dyslipidemics. Overall 12-month outcome rates were: MACE 5.5%; cardiac death 0.8%; STEMI 0.8%; NSTEMI 1.6% and revascularization 2.3%. Conclusion: This study provides important information regarding the mid-term safety and efficacy of the Endeavor zotarolimus-eluting stent. Frequency of clinical outcomes including cardiac death, myocardial infarction, and revascularization were low and consistent with pooled results of other major trials.
Publication Details
Page(s) 196-200
DOI DOI not available
Published Journal: Pakistan Heart Journal, Volume: 45, Issue: 3, Year: 2012

Request the full text from PASTIC

Keywords
Coronary artery disease, Myocardial Infarction, Unstable angina, Stable angina, Drug Eluting Stents
0

Citations

0

Downloads

49

Views